Creative Planning’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.2M | Buy |
72,434
+4,816
| +7% | +$824K | 0.01% | 602 |
|
|
2025
Q4 | $11.4M | Buy |
67,618
+245
| +0.4% | +$39.8K | 0.01% | 565 |
|
|
2025
Q3 | $9.73M | Buy |
67,373
+1,927
| +3% | +$263K | 0.01% | 572 |
|
|
2025
Q2 | $8.28M | Sell |
65,446
-2,180
| -3% | -$268K | 0.01% | 572 |
|
|
2025
Q1 | $8.65M | Buy |
67,626
+1,161
| +2% | +$157K | 0.01% | 534 |
|
|
2024
Q4 | $8.79M | Sell |
66,465
-192
| -0.3% | -$27K | 0.01% | 490 |
|
|
2024
Q3 | $9.71M | Sell |
66,657
-1,245
| -2% | -$180K | 0.01% | 444 |
|
|
2024
Q2 | $9.32M | Buy |
67,902
+1,905
| +3% | +$254K | 0.01% | 433 |
|
|
2024
Q1 | $9.06M | Buy |
65,997
+1,063
| +2% | +$145K | 0.01% | 431 |
|
|
2023
Q4 | $8.82M | Sell |
64,934
-1,137
| -2% | -$139K | 0.02% | 408 |
|
|
2023
Q3 | $8.08M | Buy |
66,071
+3,290
| +5% | +$418K | 0.01% | 405 |
|
|
2023
Q2 | $7.97M | Sell |
62,781
-768
| -1% | -$99.8K | 0.01% | 399 |
|
|
2023
Q1 | $8.21M | Sell |
63,549
-1,002
| -2% | -$131K | 0.01% | 377 |
|
|
2022
Q4 | $8.47M | Buy |
64,551
+23,799
| +58% | +$3.08M | 0.01% | 369 |
|
|
2022
Q3 | $4.77M | Sell |
40,752
-26,744
| -40% | -$3.32M | 0.01% | 452 |
|
|
2022
Q2 | $7.94M | Buy |
67,496
+26,676
| +65% | +$3.17M | 0.01% | 360 |
|
|
2022
Q1 | $5.32M | Sell |
40,820
-5,188
| -11% | -$676K | 0.01% | 437 |
|
|
2021
Q4 | $7.02M | Sell |
46,008
-905
| -2% | -$140K | 0.01% | 345 |
|
|
2021
Q3 | $7.58M | Buy |
46,913
+777
| +2% | +$131K | 0.01% | 317 |
|
|
2021
Q2 | $7.55M | Sell |
46,136
-7,712
| -14% | -$1.19M | 0.01% | 315 |
|
|
2021
Q1 | $8.11M | Buy |
53,848
+126
| +0.2% | +$20K | 0.02% | 312 |
|
|
2020
Q4 | $8.14M | Buy |
53,722
+101
| +0.2% | +$14.4K | 0.02% | 291 |
|
|
2020
Q3 | $7.26M | Buy |
53,621
+21,939
| +69% | +$2.98M | 0.02% | 265 |
|
|
2020
Q2 | $4.33M | Sell |
31,682
-734
| -2% | -$93.6K | 0.01% | 306 |
|
|
2020
Q1 | $3.49M | Sell |
32,416
-8,954
| -22% | -$1.03M | 0.01% | 303 |
|
|
2019
Q4 | $4.99M | Buy |
41,370
+5,264
| +15% | +$587K | 0.02% | 299 |
|
|
2019
Q3 | $3.59M | Sell |
36,106
-648
| -2% | -$67.8K | 0.01% | 353 |
|
|
2019
Q2 | $4.01M | Sell |
36,754
-7,583
| -17% | -$807K | 0.01% | 332 |
|
|
2019
Q1 | $4.96M | Sell |
44,337
-5,529
| -11% | -$606K | 0.02% | 278 |
|
|
2018
Q4 | $4.81M | Buy |
49,866
+9,089
| +22% | +$965K | 0.02% | 253 |
|
|
2018
Q3 | $4.97M | Buy |
40,777
+452
| +1% | +$53.2K | 0.02% | 271 |
|
|
2018
Q2 | $4.43M | Sell |
40,325
-225
| -0.6% | -$24.1K | 0.02% | 278 |
|
|
2018
Q1 | $4.33M | Sell |
40,550
-8,067
| -17% | -$894K | 0.02% | 280 |
|
|
2017
Q4 | $5.19M | Buy |
48,617
+1,886
| +4% | +$202K | 0.02% | 235 |
|
|
2017
Q3 | $5.2M | Buy |
46,731
+1,428
| +3% | +$153K | 0.02% | 229 |
|
|
2017
Q2 | $4.68M | Buy |
45,303
+651
| +1% | +$64.1K | 0.02% | 230 |
|
|
2017
Q1 | $4.37M | Sell |
44,652
-11,667
| -21% | -$1.12M | 0.02% | 231 |
|
|
2016
Q4 | $4.98M | Buy |
56,319
+15,417
| +38% | +$1.4M | 0.03% | 205 |
|
|
2016
Q3 | $3.95M | Sell |
40,902
-3,729
| -8% | -$355K | 0.03% | 232 |
|
|
2016
Q2 | $3.83M | Sell |
44,631
-231
| -0.5% | -$20.7K | 0.03% | 205 |
|
|
2016
Q1 | $3.9M | Buy |
44,862
+8,313
| +23% | +$743K | 0.03% | 187 |
|
|
2015
Q4 | $4.12M | Sell |
36,549
-30,468
| -45% | -$3.31M | 0.03% | 191 |
|
|
2015
Q3 | $6.78M | Buy |
67,017
+9,975
| +17% | +$1.2M | 0.06% | 128 |
|
|
2015
Q2 | $7.02M | Buy |
57,042
+4,083
| +8% | +$489K | 0.06% | 124 |
|
|
2015
Q1 | $6.06M | Buy |
52,959
+8,400
| +19% | +$926K | 0.06% | 132 |
|
|
2014
Q4 | $4.51M | Buy |
44,559
+14,460
| +48% | +$1.41M | 0.05% | 153 |
|
|
2014
Q3 | $2.75M | Buy |
30,099
+2,661
| +10% | +$234K | 0.03% | 193 |
|
|
2014
Q2 | $2.35M | Sell |
27,438
-147
| -0.5% | -$11.6K | 0.03% | 200 |
|
|
2014
Q1 | $2.17M | Buy |
27,585
+5,010
| +22% | +$417K | 0.03% | 190 |
|
|
2013
Q4 | $1.71M | Buy |
22,575
+4,263
| +23% | +$302K | 0.03% | 207 |
|
|
2013
Q3 | $1.28M | Buy |
18,312
+3,804
| +26% | +$249K | 0.03% | 222 |
|
|
2013
Q2 | $841K | Buy |
+14,508
| New | +$839K | 0.02% | 274 |
|
Other funds holding IBB
CB
Creative Planning's IBB Position: Q1 2026 in Review
Creative Planning increased its iShares Biotechnology ETF (IBB) stake by 7.1% in Q1 2026, buying an estimated $824K and bringing the position to 72,434 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #602.
Creative Planning first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Creative Planning held 72,434 shares of iShares Biotechnology ETF worth $12.2M as of Q1 2026.
- Creative Planning bought 4,816 iShares Biotechnology ETF shares in Q1 2026, an estimated $824K.
- iShares Biotechnology ETF made up 0.01% of Creative Planning's portfolio in Q1 2026, its #602 holding.
- Creative Planning first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.